Patents by Inventor Bob M. Moore

Bob M. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tri-aryl/heteroaromatic cannabinoids and use thereof
    Patent number: 9139546
    Abstract: Cannabinoid derivatives according to formula (I) are disclosed wherein, X, Y, R1, R2, and W can have the definitions provided herein. Without limitation, use of such compounds, their salts or pro-drug, or compositions containing the compounds, salts, or pro-drug, to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: September 22, 2015
    Assignee: The University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Himanshu Bhattacharjee, Suni Mustafa
  • Pyridine non-classical cannabinoid compounds and related methods of use
    Patent number: 8809373
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: August 19, 2014
    Assignee: The University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • Pyrimidine non-classical cannabinoid compounds and related methods of use
    Patent number: 8541431
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: September 24, 2013
    Assignee: The University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa, Patrick Allison
  • Benzofuran cannabinoid compounds and related methods of use
    Patent number: 8476309
    Abstract: Furanopyridine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: July 2, 2013
    Assignee: The University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • Pyridine classical cannabinoid compounds and related methods of use
    Patent number: 8476439
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: July 2, 2013
    Assignee: The University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • PYRIMIDINE CLASSICAL CANNABINOID COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20130158052
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z are as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors, such as, for example, inflammation.
    Type: Application
    Filed: December 3, 2012
    Publication date: June 20, 2013
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa, Patrick Allison
  • Furanopyridine cannabinoid compounds and related methods of use
    Patent number: 8431595
    Abstract: Furanopyridine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: April 30, 2013
    Assignee: The University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • Pyrimidine non-classical cannabinoid compounds and related methods of use
    Patent number: 8389534
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Grant
    Filed: October 14, 2009
    Date of Patent: March 5, 2013
    Assignee: The University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa, Patrick Allison
  • Pyridine non-classical cannabinoid compounds and related methods of use
    Patent number: 8349876
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Grant
    Filed: October 14, 2009
    Date of Patent: January 8, 2013
    Assignee: The University of Tennesee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • Pyrimidine classical cannabinoid compounds and related methods of use
    Patent number: 8324228
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z are as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors, such as, for example, inflammation.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: December 4, 2012
    Assignee: University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa, Patrick Allison
  • PYRIDINE CLASSICAL CANNABINOID COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20120220773
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Application
    Filed: February 27, 2012
    Publication date: August 30, 2012
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • PYRIDINE NON-CLASSICAL CANNABINOID COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20120196900
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Application
    Filed: April 16, 2012
    Publication date: August 2, 2012
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • Pyridine non-classical cannabinoid compounds and related methods of use
    Patent number: 8158654
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: April 17, 2012
    Assignee: The University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • Pyridine classical cannabinoid compounds and related methods of use
    Patent number: 8124771
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: February 28, 2012
    Assignee: University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • PYRIMIDINE CLASSICAL CANNABINOID COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20120004250
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z are as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors, such as, for example, inflammation.
    Type: Application
    Filed: September 19, 2011
    Publication date: January 5, 2012
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa, Patrick Allison
  • Pyrimidine classical cannabinoid compounds and related methods of use
    Patent number: 8022078
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: September 20, 2011
    Assignee: University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa, Patrick Allison
  • Tri-Aryl/Heteroaromatic Cannabinoids and Use Thereof
    Publication number: 20110207748
    Abstract: Cannabinoid derivatives according to formula (I) are disclosed wherein, X, Y, R1, R2, and W can have the definitions provided herein. Without limitation, use of such compounds, their salts or pro-drug, or compositions containing the compounds, salts, or pro-drug, to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
    Type: Application
    Filed: February 10, 2011
    Publication date: August 25, 2011
    Inventors: Bob M. Moore, II, Himanshu Bhattacharjee, Suni Mustafa
  • FURANOPYRIMIDINE CANNABINOID COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20110046163
    Abstract: Furanopyrimidine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
    Type: Application
    Filed: August 20, 2010
    Publication date: February 24, 2011
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • FURANOPYRIDINE CANNABINOID COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20110046176
    Abstract: Furanopyridine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
    Type: Application
    Filed: August 20, 2010
    Publication date: February 24, 2011
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20110046175
    Abstract: Furanopyridine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
    Type: Application
    Filed: August 20, 2010
    Publication date: February 24, 2011
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa